全文获取类型
收费全文 | 3748篇 |
免费 | 267篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 115篇 |
儿科学 | 167篇 |
妇产科学 | 100篇 |
基础医学 | 456篇 |
口腔科学 | 129篇 |
临床医学 | 427篇 |
内科学 | 539篇 |
皮肤病学 | 69篇 |
神经病学 | 280篇 |
特种医学 | 411篇 |
外科学 | 319篇 |
综合类 | 61篇 |
一般理论 | 1篇 |
预防医学 | 210篇 |
眼科学 | 108篇 |
药学 | 225篇 |
肿瘤学 | 410篇 |
出版年
2021年 | 30篇 |
2020年 | 18篇 |
2019年 | 36篇 |
2018年 | 52篇 |
2017年 | 28篇 |
2016年 | 37篇 |
2015年 | 44篇 |
2014年 | 60篇 |
2013年 | 105篇 |
2012年 | 95篇 |
2011年 | 101篇 |
2010年 | 97篇 |
2009年 | 77篇 |
2008年 | 98篇 |
2007年 | 130篇 |
2006年 | 148篇 |
2005年 | 151篇 |
2004年 | 137篇 |
2003年 | 116篇 |
2002年 | 101篇 |
2001年 | 89篇 |
2000年 | 92篇 |
1999年 | 131篇 |
1998年 | 131篇 |
1997年 | 96篇 |
1996年 | 100篇 |
1995年 | 83篇 |
1994年 | 94篇 |
1993年 | 86篇 |
1992年 | 92篇 |
1991年 | 83篇 |
1990年 | 91篇 |
1989年 | 110篇 |
1988年 | 80篇 |
1987年 | 104篇 |
1986年 | 74篇 |
1985年 | 76篇 |
1984年 | 71篇 |
1983年 | 64篇 |
1982年 | 53篇 |
1981年 | 47篇 |
1980年 | 53篇 |
1979年 | 59篇 |
1978年 | 54篇 |
1977年 | 42篇 |
1976年 | 44篇 |
1975年 | 35篇 |
1974年 | 36篇 |
1973年 | 21篇 |
1970年 | 22篇 |
排序方式: 共有4027条查询结果,搜索用时 16 毫秒
101.
MacDonald I; Wang H; Grand R; Armitage RJ; Fanslow WC; Gregory CD; Gordon J 《Blood》1996,87(3):1147-1154
Group I Burkitt lymphoma (BL) cell lines, which retain the original biopsy phenotype, have been shown to enter apoptosis in response to a number of external stimuli including serum deprivation, thermal shock, addition of calcium ionophore, and ligation of surface immunoglobulin (Ig) by antibody. Transforming growth factor-beta 1 (TGF beta 1) is known to cause growth arrest in BL lines. Here we show that while it is by itself capable of promoting some degree of apoptosis in group IBL cells, TGF beta 1 cooperates with anti-immunoglobulin to this end. Trimeric soluble recombinant human CD40 ligand (sCD40L) was able to inhibit apoptosis induced by the combination of agonists to some degree, but such rescue proved to be short-lived. Both TGF beta 1 and anti-Ig individually caused BL cells to undergo growth arrest at the G1 phase of cell cycle before their entry into apoptosis: the consequence of sCD40L addition was to maintain the cells in cycle for longer. No induction of the apoptosis-protecting gene, bcl-2, occurred in the presence of sCD40L. These findings are discussed, particularly highlighting the relationship existing between survival and the cell cycle. The strong cooperative effects observed between anti-Ig and TGF beta 1 in promoting apoptosis and the inability of CD40 to signal for long-term rescue raise the potential for a novel therapeutic attack on B-cell lymphoma. 相似文献
102.
Moderation of hemophilia A phenotype by the factor V R506Q mutation 总被引:11,自引:1,他引:11
Nichols WC; Amano K; Cacheris PM; Figueiredo MS; Michaelides K; Schwaab R; Hoyer L; Kaufman RJ; Ginsburg D 《Blood》1996,88(4):1183-1187
Although many examples of unrelated hemophilia A patients carrying identical point mutations in the factor VIII (FVIII) gene have been reported, the clinical phenotype is not always the same among patients sharing the same molecular defect. Possible explanations for this discrepancy include undetected additional mutations in the FVIII gene or coinheritance of mutations at other genetic loci that modulate FVIII function. We report molecular genetic analysis of potential modifying genes in two sets of unrelated patients carrying common FVIII missense mutations but exhibiting different levels of clinical severity. Both mutations (FVIII R1689C and R2209Q) are associated with severe hemophilia A in some patients and mild/moderate disease in others. The common von Willebrand disease type 2N mutation (R91Q) was excluded as a modifying factor in these groups of patients. However, analysis of the recently described factor V (FV) R506Q mutation (leading to activated protein C resistance) identified a correlation of inheritance of this defect with reduced hemophilia A severity. Two moderately affected hemophilia A patients, each with either of two FVIII gene mutations, were heterozygous for FV R506Q, whereas two severely affected patients and two moderately affected patients were homozygous normal at the FV locus. Our results suggest that coinheritance of the FV R506Q mutation may be an important determinant of clinical phenotype in hemophilia A and that modification of the protein C pathway may offer a new strategy for the treatment of FVIII deficiency. 相似文献
103.
C K Osborne G Bolan M E Monaco M E Lippman 《Proceedings of the National Academy of Sciences of the United States of America》1976,73(12):4536-4540
The mechanisms of steroid and peptide hormone action in human breast cancer are poorly understood. We have previously characterized a cell line of human breast cancer in long-term tissue culture that possesses various steroid hormone receptors and responses, providing a model for the study of steroid hormone action. The present studies describe a human breast cancer in vitro that responds to physiologie concentrations of insulin with an increased rate of macromolecular synthesis and growth. Thymidine and uridine incorporation in cells in serum-free medium are stimulated by 10(-11) M insulin and are maximal with 10(-8) M. Leucine incorporation is stimulated by 5 X 10(-11) M insulin and is maximal with 10(-9) M. Significant stimulation of uridine and leucine incorporation is evident by 3 hr and maximal by 10 hr. A 10-hr lag period exists for insulin stimulation of thymidine incorporation, which is maximal form 14 to 24 hr. The effect of 10(-8) M insulin on macromolecular synthesis is accompanied by a 69% increase above controls in the number of cells after 24 hr. The effect on macromolecular synthesis is observed in glucose-free medium. Insulin's effect on protein synthesis is not blocked by inhibition of RNA synthesis with actinomycin D. Glucocorticoids partially inhibit the action of insulin in these cells. This system provides a model for studying insulin action, and suggests that some human breast cancer may show growth regulation by insulin. 相似文献
104.
105.
Assessment of aldehyde dehydrogenase in viable cells 总被引:3,自引:4,他引:3
Jones RJ; Barber JP; Vala MS; Collector MI; Kaufmann SH; Ludeman SM; Colvin OM; Hilton J 《Blood》1995,85(10):2742-2746
Cytosolic aldehyde dehydrogenase (ALDH), an enzyme responsible for oxidizing intracellular aldehydes, has an important role in ethanol, vitamin A, and cyclophosphamide metabolism. High expression of this enzyme in primitive stem cells from multiple tissues, including bone marrow and intestine, appears to be an important mechanism by which these cells are resistant to cyclophosphamide. However, although hematopoietic stem cells (HSC) express high levels of cytosolic ALDH, isolating viable HSC by their ALDH expression has not been possible because ALDH is an intracellular protein. We found that a fluorescent aldehyde, dansyl aminoacetaldehyde (DAAA), could be used in flow cytometry experiments to isolate viable mouse and human cells based on their ALDH content. The level of dansyl fluorescence exhibited by cells after incubation with DAAA paralleled cytosolic ALDH levels determined by Western blotting and the sensitivity of the cells to cyclophosphamide. Moreover, DAAA appeared to be a more sensitive means of assessing cytosolic ALDH levels than Western blotting. Bone marrow progenitors treated with DAAA proliferated normally. Furthermore, marrow cells expressing high levels of dansyl fluorescence after incubation with DAAA were enriched for hematopoietic progenitors. The ability to isolate viable cells that express high levels of cytosolic ALDH could be an important component of methodology for identifying and purifying HSC and for studying cyclophosphamide-resistant tumor cell populations. 相似文献
106.
107.
Anal cancer is one of the most common non‐AIDS‐defining malignancies in the era of combination antiretroviral therapy. Its precursor lesion, anal intraepithelial neoplasia (AIN), is highly prevalent in HIV‐infected populations. More than 90% of anal squamous cell cancers are attributable to human papillomavirus (HPV). While the biology of HPV‐related intraepithelial neoplasia is consistent across lower anogenital sites, the natural history of AIN is not well established and cannot be assumed to be identical to that of cervical intraepithelial neoplasia. Screening strategies to prevent anal cancer should be developed based on robust natural history data in HIV‐infected and uninfected populations. Likewise, treatments need to be tested in randomized clinical trials, and reserved for those at significant risk of progression to cancer. This review covers the epidemiology, pathogenesis and immunology of HPV infection, AIN and anal cancer, and summarizes the current diagnosis, screening and treatment strategies in HIV‐infected adults. 相似文献
108.
Renfang Mao Wen Bu Chad J Creighton Pingju Zheng Sanjeev Vasudevan Lei An Jinshu Yang Yi‐Jue Zhao Huiyuan Zhang Xiao‐Nan Li Pulivarthi H Rao Eastwood Leung Yong‐Jie Lu Joe W Gray Rachel Schiff Susan G Hilsenbeck C Kent Osborne Jianhua Yang Hong Zhang 《The Journal of pathology》2014,232(1):75-86
Gene amplifications in the 17q chromosomal region are observed frequently in breast cancers. An integrative bioinformatics analysis of this region nominated the MAP3K3 gene as a potential therapeutic target in breast cancer. This gene encodes mitogen‐activated protein kinase kinase kinase 3 (MAP3K3/MEKK3), which has not yet been reported to be associated with cancer‐causing genetic aberrations. We found that MAP3K3 was amplified in approximately 8–20% of breast cancers. Knockdown of MAP3K3 expression significantly inhibited cell proliferation and colony formation in MAP3K3‐amplified breast cancer cell lines MCF‐7 and MDA‐MB‐361 but not in MAP3K3 non‐amplified breast cancer cells. Knockdown of MAP3K3 expression in MAP3K3‐amplified breast cancer cells sensitized breast cancer cells to apoptotic induction by TNFα and TRAIL, as well as doxorubicin, VP‐16 and fluorouracil, three commonly used chemotherapeutic drugs for treating breast cancer. In addition, ectopic expression of MAP3K3, in collaboration with Ras, induced colony formation in both primary mouse embryonic fibroblasts and immortalized human breast epithelial cells (MCF‐10A). Combined, these results suggest that MAP3K3 contributes to breast carcinogenesis and may endow resistance of breast cancer cells to cytotoxic chemotherapy. Therefore, MAP3K3 may be a valuable therapeutic target in patients with MAP3K3‐amplified breast cancers, and blocking MAP3K3 kinase activity with a small molecule inhibitor may sensitize MAP3K3‐amplified breast cancer cells to chemotherapy. Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. 相似文献
109.
Gerrit A. van Essen Jiri Beran Jeanne‐Marie Devaster Christelle Durand Xavier Duval Meral Esen Ann R. Falsey Gregory Feldman Pierre Gervais Bruce L. Innis Martina Kovac Odile Launay Geert Leroux‐Roels Janet E. McElhaney Shelly McNeil Mohammed Oujaa Jan Hendrik Richardus Guillermo Ruiz‐Palacios Richard H. Osborne Lidia Oostvogels 《Influenza and other respiratory viruses》2014,8(4):452-462
110.